ISOLF.US Isodiol International Inc

Healthcare Pharmaceuticals USA Stocks
0.0001 USD
Close of Nov 15, 2026
0.0001 0.0001
Market cap
USD 4.91K
P/E
-
P/B
4.70x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Dec 2019.

Is ISOLF.US undervalued?

Graham number

The Graham number of Isodiol International Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Isodiol International Inc fundamental analysis

No fundamental analysis for Isodiol International Inc yet.

Isodiol International Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Isodiol International Inc

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for c…

Full company profile